Nate Rott

We brought out the begging bowl.

Okay, well, that's good.

So were they able to get another $45 million?

Okay, that's still money, but a lot less money.

Did they have to scale back their ambitions then?

Ooh, I hear a door.

Are we going back into that noisy seven-door freezer room?

Okay, so this is like a super antibody.

Okay, so they usually emerge too late, but is there a way for the researchers to somehow, like, coax the human immune system, let's say, to, like, produce these antibodies before they become infected with HIV so they have some defenses?

Okay, cool.

Do we have a sense, Ari, of when the first shots of this new vaccine will start going into people's arms?

Wow.

I'm excited to hear how this goes.

Thank you so much, Ari, for bringing us this story.

Ari Daniel is a freelance science reporter.

And short wavers, if you like this episode, follow us on the NPR app or wherever you listen to podcasts.

Also, check out our episodes on when your brain is fully developed and creative.

Reporting for this story was supported by a grant from the Pulitzer Center.

Thank you, Pulitzer Center.

The Gates Foundation is a financial supporter of NPR.